U.S. FDA Issues New Guidance to Medical Product Developers Addressing Virus Variants

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) announced guidances for medical product developers, specifically covering vaccines, diagnostics, and therapeutics products, to address the emergence and potential future emergence of variants of the SARS-CoV-2 coronavirus.

Read More